Massachusetts Nonprofits Are Forging New Ways to Remain Vital, According to Publisher of massnonprofit.org
March 17, 2011 11:29 ET
|
massnonprofit.org
BROOKLINE, MA--(Marketwire - March 17, 2011) - Nonprofit organizations in Massachusetts are forging creative responses to a changing operating environment that is characterized by higher demand...
Alliance for the Prudent Use of Antibiotics Lauds FDA for Action on Antimicrobial Drugs in Food-Producing Animals
June 29, 2010 13:23 ET
|
APUA
BOSTON, MA--(Marketwire - June 29, 2010) - The Alliance for the Prudent Use of Antibiotics (APUA), the leading, independent global organization dedicated to preserving the power of existing...
HemaQuest Pharmaceuticals Receives European Orphan Medicinal Product Designations for Therapeutic to Treat Hemoglobin Disorders
March 26, 2009 12:54 ET
|
HemaQuest Pharmaceuticals
BOSTON, MA--(Marketwire - March 26, 2009) - HemaQuest Pharmaceuticals today announced that
it has received two orphan medicinal product designations from the European
Commission for its product...
HemaQuest Pharmaceuticals Announces Clinical Progress on New Sickle Cell Anemia Drug
December 09, 2008 12:01 ET
|
HemaQuest Pharmaceuticals
SAN FRANCISCO, CA--(Marketwire - December 9, 2008) - HemaQuest Pharmaceuticals announced
today the successful completion of Phase 1 clinical trials of HQK-1001, an
orally-administered therapeutic...
Fashion Accessories First Acquires Catherine Stein Design of New York
November 13, 2008 10:59 ET
|
Fashion Accessories First, Inc.
GREENVILLE, RI--(Marketwire - November 13, 2008) - Fashion Accessories First, Inc. (FAF), one
of the leading suppliers of fashion jewelry and accessories to retailers
worldwide, today announced that...
HemaQuest Pharmaceuticals Receives Orphan Drug Designations for Therapeutic to Treat Hemoglobin Disorders
November 04, 2008 09:00 ET
|
HemaQuest Pharmaceuticals
BOSTON, MA--(Marketwire - November 4, 2008) - HemaQuest Pharmaceuticals today announced that
the U.S. Food and Drug Administration (FDA) has awarded the company orphan
drug designations for sickle...
HemaQuest Announces Initiation of Phase I Clinical Trial of HQK-1001 to Treat Hemoglobin Disorders
January 17, 2008 09:00 ET
|
HemaQuest Pharmaceuticals
NEWTON, MA--(Marketwire - January 17, 2008) - HemaQuest Pharmaceuticals, which received its
first round of venture financing three months ago, today announced that the
U.S. Food and Drug...
HemaQuest Announces $20M Series A Financing for Anemia Drug Development
November 01, 2007 10:30 ET
|
HemaQuest Pharmaceuticals
NEWTON, MA--(Marketwire - November 1, 2007) - HemaQuest Pharmaceuticals, a new company
developing proprietary small molecule therapeutics to treat serious blood
disorders, today announced that it...